Literature DB >> 27898284

Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.

Iben R Andersen1, Esben Søndergaard1,2,3, Lars P Sørensen1, Birgitte Nellemann1, Lars C Gormsen4, Michael D Jensen2, Søren Nielsen1.   

Abstract

Context: Lipoprotein lipase (LPL) activity is considered the rate-limiting step of very-low-density-lipoprotein triglycerides (VLDL-TG) tissue storage, and has been suggested to relate to the development of obesity as well as insulin resistance and type 2 diabetes. Objective: The objective of the study was to assess the relationship between the quantitative storage of VLDL-TG fatty acids and LPL activity and other storage factors in muscle and adipose tissue. In addition, we examine whether such relations were influenced by type 2 diabetes. Design: We recruited 23 men (12 with type 2 diabetes, 11 nondiabetic) matched for age and body mass index. Postabsorptive VLDL-TG muscle and subcutaneous adipose tissue (abdominal and leg) quantitative storage was measured using tissue biopsies in combination with a primed-constant infusion of ex vivo triolein labeled [1-14C]VLDL-TG and a bolus infusion of ex vivo triolein labeled [9,10-3H]VLDL-TG. Biopsies were analyzed for LPL activity and cellular storage factors.
Results: VLDL-TG storage rate was significantly greater in men with type 2 diabetes compared with nondiabetic men in muscle tissue (P = 0.02). We found no significant relationship between VLDL-TG storage rate and LPL activity or other storage factors in muscle or adipose tissue. However, LPL activity correlated with fractional VLDL-TG storage in abdominal fat (P = 0.04). Conclusions: Men with type 2 diabetes have increased VLDL-TG storage in muscle tissue, potentially contributing to increased intramyocellular triglyceride and ectopic lipid deposition. Neither muscle nor adipose tissue storage rates were related to LPL activity. This argues against LPL as a rate-limiting step in the postabsorptive quantitative storage of VLDL-TG.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27898284     DOI: 10.1210/jc.2016-2979

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Unexplained reciprocal regulation of diabetes and lipoproteins.

Authors:  Sei Higuchi; M Concepción Izquierdo; Rebecca A Haeusler
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

2.  Transcription of mtDNA and dyslipidemia are ameliorated by aerobic exercise in type 2 diabetes.

Authors:  Sandra Aparecida Benite-Ribeiro; Kamila Lauany Lucas-Lima; Jessica N Jones; Julia Matzenbacher Dos Santos
Journal:  Mol Biol Rep       Date:  2020-08-17       Impact factor: 2.316

3.  Effects of meal ingestion on intramyocellular ceramide concentrations and fractional de novo synthesis in humans.

Authors:  Jin Ook Chung; Christina Koutsari; Agnieszka Urszula Blachnio-Zabielska; Kazanna C Hames; Michael D Jensen
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-09-26       Impact factor: 4.310

4.  Subcutaneous Adipose Tissue Metabolic Function and Insulin Sensitivity in People With Obesity.

Authors:  Han-Chow E Koh; Stephan van Vliet; Terri A Pietka; Gretchen A Meyer; Babak Razani; Richard Laforest; Robert J Gropler; Bettina Mittendorfer
Journal:  Diabetes       Date:  2021-07-15       Impact factor: 9.337

5.  Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial.

Authors:  Hiroyuki Hirai; Moritake Higa; Takeshi Morimoto; Mio Sakuma; Osamu Arasaki; Takashi Nomiyama; Koichi Node; Shinichiro Ueda; Michio Shimabukuro
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.